Komori
Toba (7472) · RiskUpdated the valuation difference on available-for-sale securities at the end of the interim period

Market Price Risk on Investment Securities

First written in FY2017. 2 of 25 entries say "Materialised", first in FY2019. Latest entry: FY2027-H1.

25entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017OtherFY2021 – FY2027-H12017: 120172018: 020182019: 220192020: 420202021: 320212022: 420222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Valuation loss due to declines in the market value of securities heldA theme 266 companies write about · 263 as a headwind · 3 as a tailwind

The whole theme swung hardest in 2019: 66 of 143 companies on the "Worse" side.

38 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 268 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Updated the valuation difference on available-for-sale securities at the end of the interim periodAnnual report

    「Increase in valuation difference on available-for-sale securities (¥244 million)」

    The valuation difference on available-for-sale securities increased by ¥244 million from the end of the previous fiscal year to ¥1,648,536,000.
  2. FY2026Updated the valuation difference on available-for-sale securities at the end of the fiscal yearAnnual report

    「Valuation difference on available-for-sale securities 1,072,845 1,403,925」

    The valuation difference on available-for-sale securities increased from ¥1,072.845 million at the end of the previous fiscal year to ¥1,403.925 million.
  3. FY2026-H1Updated the valuation difference on available-for-sale securities at the end of the interim periodAnnual report

    「Increase in valuation difference on available-for-sale securities (¥185 million)」

    The valuation difference on available-for-sale securities increased by ¥185 million from ¥1,072.845 million at the end of the previous fiscal year to ¥1,258.218 million.
  4. FY2025Updated the valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities 1,305,285 1,072,845」

    The valuation difference on available-for-sale securities decreased from ¥1,305.285 million at the end of the previous fiscal year to ¥1,072.845 million.
  5. FY2025-H1Updated the valuation difference at the end of the interim periodAnnual report

    「Decrease in valuation difference on available-for-sale securities (¥145 million)」

    The valuation difference on available-for-sale securities decreased by ¥145.552 million from the end of the previous fiscal year to ¥1,159.732 million.
  6. FY2024Updated the valuation difference on available-for-sale securities at the end of the fiscal yearAnnual report

    「Valuation difference on available-for-sale securities 935,577 1,305,285」

    The valuation difference on available-for-sale securities increased from ¥935.577 million at the end of FY2023 to ¥1,305.285 million at the end of FY2024.
  7. FY2024-Q3Updated the valuation difference on available-for-sale securities at the end of the third quarterAnnual report

    「Increase in valuation difference on available-for-sale securities (¥217 million)」

    The valuation difference on available-for-sale securities increased by ¥217 million from the end of the previous fiscal year to ¥1,153.52 million.
  8. FY2024-Q2Updated the valuation difference at the end of the second quarterAnnual report

    「Increase in valuation difference on available-for-sale securities (¥160 million)」

    The valuation difference on available-for-sale securities increased by ¥160.086 million from ¥935.577 million at the end of the previous fiscal year, reaching ¥1,095.663 million at the end of the second quarter.
  9. FY2024-Q1Updated the valuation difference at the end of the first quarterAnnual report

    「Increase in valuation difference on available-for-sale securities (¥231 million)」

    The valuation difference on available-for-sale securities increased by ¥231.211 million from ¥935.577 million at the end of FY2023, reaching ¥1,166.788 million at the end of FY2024-Q1.
  10. FY2023Updated the valuation difference on available-for-sale securities at the end of the fiscal yearAnnual report

    「Valuation difference on available-for-sale securities 1,032,246 935,577」

    The valuation difference on available-for-sale securities decreased from ¥1,032.246 million at the end of FY2022 to ¥935.577 million at the end of FY2023.
  11. FY2023-Q3Updated the valuation difference on available-for-sale securities at the end of the third quarterAnnual report

    「Valuation difference on available-for-sale securities 1,032,246 943,397」

    The valuation difference on available-for-sale securities decreased from ¥1,032.246 million at the end of the previous consolidated fiscal year to ¥943.397 million at the end of the third quarter.
  12. FY2023-Q2Updated the valuation difference on available-for-sale securities at the end of the second quarterAnnual report

    「Valuation difference on available-for-sale securities 1,032,246 898,562」

    The valuation difference on available-for-sale securities decreased from ¥1,032.246 million at the end of FY2022 to ¥898.562 million at the end of FY2023-Q2.
  13. FY2023-Q1Updated the valuation difference on available-for-sale securities at the end of the first quarterAnnual report

    「Valuation difference on available-for-sale securities 1,032,246 925,469」

    The valuation difference on available-for-sale securities decreased from ¥1,032.246 million at the end of FY2022 to ¥925.469 million at the end of FY2023-Q1.
  14. FY2022Updated the valuation difference on available-for-sale securities at the end of the fiscal yearAnnual report

    「Valuation difference on available-for-sale securities 1,067,291 1,032,246」

    The valuation difference on available-for-sale securities decreased from ¥1,067.291 million at the end of FY2021 to ¥1,032.246 million at the end of FY2022.
  15. FY2022-Q3Updated the valuation difference on available-for-sale securities at the end of the third quarterAnnual report

    「Valuation difference on available-for-sale securities 1,067,291 1,181,245」

    The valuation difference on available-for-sale securities increased from ¥1,067.291 million at the end of FY2021 to ¥1,181.245 million at the end of FY2022-Q3.
  16. FY2022-Q2Updated the valuation difference on available-for-sale securities at the end of the second quarterAnnual report

    「Valuation difference on available-for-sale securities 1,067,291 1,154,426」

    The valuation difference on available-for-sale securities increased from ¥1,067.291 million at the end of FY2021 to ¥1,154.426 million at the end of FY2022-Q2.
  17. FY2021Updated the valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities 662,236 1,067,291」

    The valuation difference on available-for-sale securities increased from ¥662.236 million at the end of FY2020 to ¥1,067.291 million at the end of FY2021.
  18. FY2021-Q3MaterialisedAnnual report

    「Loss on valuation of investment securities - 1,227」

    The company recorded a ¥1.227 million loss on valuation of investment securities for the nine months ended FY2021-Q3. The valuation difference on available-for-sale securities also increased from ¥662.236 million at the end of the previous fiscal year to ¥1,112.522 million.
  19. FY2021-Q2Updated the valuation difference on available-for-sale securities at the end of the second quarterAnnual report

    「Valuation difference on available-for-sale securities 662,236 987,860」

    The valuation difference on available-for-sale securities increased from ¥662.236 million at the end of FY2020 to ¥987.86 million at the end of FY2021-Q2.
  20. FY2021-Q1Updated the valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities 662,236 890,588」

    The valuation difference on available-for-sale securities increased from ¥662.236 million at the end of FY2020 to ¥890.588 million at the end of FY2021-Q1.
  21. FY2020Updated the valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities 651,911 662,236」

    The valuation difference on available-for-sale securities increased from ¥651.911 million at the end of FY2019 to ¥662.236 million at the end of FY2020.
  22. FY2020-Q3Updated the valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities 651,911 833,879」

    The valuation difference on available-for-sale securities increased from ¥651.911 million at the end of FY2019 to ¥833.879 million at the end of FY2020-Q3.
  23. FY2020-Q2Updated the valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities 651,911 686,819」

    The valuation difference on available-for-sale securities increased from ¥651.911 million at the end of FY2019 to ¥686.819 million at the end of FY2020-Q2.
  24. FY2019MaterialisedAnnual report

    「Valuation difference on available-for-sale securities (¥264.922 million)」

    For investment securities exposed to market price fluctuation risk, the valuation difference on available-for-sale securities decreased by ¥264.922 million, reflecting a decline in the valuation difference in the results.
  25. FY2017First statedAnnual report

    「Shares classified as investment securities are exposed to the risk of fluctuations in market prices, but they are mainly shares of companies with which the company has business relationships. Fair values determined regularly are reported to the directors.」

    The company holds shares of companies with which it has business relationships, recognizes the risk of fluctuations in market prices, and describes a management system under which fair values are reported regularly to the directors.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Toba's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.